Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value: $103M (100.0% shares, 0.0% debt)

Holdings (26)

— AMARIN CORP PLC -ADR 18.2%
Value $18.79M Shares 1,239,568 Share Price $15.16 Est. Cost/Share $6.04 Unrealized @ Report Date —
— OXFORD IMMUNOTEC GLOBAL PLC 11.0%
Value $11.34M Shares 681,812 Share Price $16.63 Est. Cost/Share $16.13 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL 10.6%
Value $10.93M Shares 2,595,855 Share Price $4.21 Est. Cost/Share $3.48 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 7.6%
Value $7.802M Shares 129,867 Share Price $60.08 * Est. Cost/Share $82.07 Unrealized @ Report Date -9.5%
— NEOS THERAPEUTICS INC 6.5%
Value $6.663M Shares 4,502,301 Share Price $1.48 Est. Cost/Share $1.82 Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS 5.0%
Value $5.102M Shares 860,449 Share Price $5.93 * Est. Cost/Share $5.84 Unrealized @ Report Date -4.7%
— APOLLO ENDOSURGERY INC 4.7%
Value $4.814M Shares 1,463,188 Share Price $3.29 Est. Cost/Share $4.60 Unrealized @ Report Date —
— OPIANT PHARMACEUTICALS INC 4.6%
Value $4.727M Shares 314,073 Share Price $15.05 Est. Cost/Share $16.03 Unrealized @ Report Date —
XOMA XOMA CORP 4.4%
Value $4.537M Shares 230,201 Share Price $19.71 * Est. Cost/Share $13.89 Unrealized @ Report Date +29.1%
— IVERIC BIO INC 4.2%
Value $4.285M Shares 3,825,903 Share Price $1.12 Est. Cost/Share $1.30 Unrealized @ Report Date —
— HTG MOLECULAR DIAGNOSTICS 3.7%
Value $3.848M Shares 5,790,269 Share Price $0.66 Est. Cost/Share $1.63 Unrealized @ Report Date —
— ADAMAS PHARMACEUTICALS INC 3.7%
Value $3.841M Shares 751,012 Share Price $5.11 Est. Cost/Share $6.83 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 3.0%
Value $3.107M Shares 3,711,999 Share Price $0.84 Est. Cost/Share $3.06 Unrealized @ Report Date —
LGND LIGAND PHARMACEUTICALS 2.9%
Value $2.983M Shares 29,965 Share Price $99.55 * Est. Cost/Share $75.54 Unrealized @ Report Date -16.9%
— NOVELION THERAPEUTICS INC 2.6%
Value $2.685M Shares 3,703,420 Share Price $0.73 Est. Cost/Share $0.73 Unrealized @ Report Date —
— APTEVO THERAPEUTICS INC 1.9%
Value $2.008M Shares 3,413,421 Share Price $0.59 Est. Cost/Share $0.90 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 1.5%
Value $1.552M Shares 2,740,417 Share Price $0.57 Est. Cost/Share $1.18 Unrealized @ Report Date —
— CORREVIO PHARMA CORP 1.0%
Value $1.019M Shares 509,356 Share Price $2.00 Est. Cost/Share $2.00 Unrealized @ Report Date —
— INTERPACE DIAGNOSTICS GROUP 0.9%
Value $922K Shares 1,160,378 Share Price $0.79 Est. Cost/Share $0.79 Unrealized @ Report Date —
— CHIASMA INC 0.5%
Value $543K Shares 109,743 Share Price $4.95 Est. Cost/Share $4.95 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 0.4%
Value $383K Shares 33,033 Share Price $11.59 * Est. Cost/Share $16.16 Unrealized @ Report Date 0.0%
— ACER THERAPEUTICS INC 0.4%
Value $364K Shares 114,175 Share Price $3.19 Est. Cost/Share $3.19 Unrealized @ Report Date —
— RETROPHIN INC 0.3%
Value $344K Shares 29,675 Share Price $11.59 Est. Cost/Share $11.59 Unrealized @ Report Date —
— AFFIMED NV 0.2%
Value $231K Shares 78,500 Share Price $2.94 Est. Cost/Share $3.04 Unrealized @ Report Date —
— DURECT CORPORATION 0.2%
Value $184K Shares 100,000 Share Price $1.84 Est. Cost/Share $1.84 Unrealized @ Report Date —
DMAC DIAMEDICA THERAPEUTICS INC 0.0%
Value $28,000 Shares 13,705 Share Price $2.04 * Est. Cost/Share $3.23 Unrealized @ Report Date 0.0%